Researchers at MIT developed a new tool to detect variable CRISPR arrays and applied it to 8.8 tera (10 12)-base pairs of prokaryotic genomic information.

In this article, we discuss the top 11 CRISPR stocks to invest in. If you want to skip our discussion of the gene editing industry, head directly to Top 5 CRISPR Stocks To Invest In. Genome ...

Thermo Fisher Scientific Inc. (NYSE:TMO) ranks among the best CRISPR stocks to buy. On June 24, Thermo Fisher Scientific Inc.

If bacteria acquire a sequence in their CRISPR array that is self-targeting, they will probably kill themselves, and this is a theme across autoimmunity, which should be avoided.

CRISPR-Cas systems have revolutionized biotechnology by offering ways to edit genes like a pair of programmable scissors. In nature, bacteria use these systems to fight off deadly viruses.

The CRISPR arrays are composed of a repeated array of short sequences, each originating from and exactly matching a nucleic acid sequence that once invaded the host.

The CRISPR arrays are composed of a repeated array of short sequences, each originating from and exactly matching a nucleic acid sequence that once invaded the host.

Modified viruses have proven a handy way to get CRISPR/Cas9 gene editing materials into the nucleus of cells – but they're expensive, difficult to scale and potentially toxic. Now, researchers ...

Results from the CRISPR-Cas Type IV-A3-mediated antibiotic-resistance re-sensitization assay conducted by the researchers. Credit: Fabienne Benz CRISPR-Cas systems have revolutionized ...

Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster therapies in its pipeline, providing "one and done" gene therapy cures.